FDA Investigator Patrick D Stone, MS

Patrick D Stone, MS has inspections in 9 countries as of 13 Sep 2023. Patrick D Stone, MS has collaborated with a combinined 3247 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
251
Last Inspection Date:
13 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100002711
Country:
United States of America, Germany, Brazil, Argentina, Canada, Denmark, Mexico, Hungary
Co-Investigator(s):
Adam C Hipko, Alanna Lmussawwir Bias, Albert F Peacock, PhD, Albert Peacock, PhD, Amanda J White, Andrace Lde Yampert, Andrea A Branche, Anh M Lac, Anthony E Keller, RPh, Anya D Lockett Evans, Arindam Dasgupta, PhD, Ashley N Williams, Audrey J Yarbrough, Barbara J White, Benjamin K Kingsley, Betsy C Galliher, Bing Lin, Blondell W Johnson, Bonita S Chester, Brackens Harris, Brian Sanders, Byungja E Marciante, Camerson E Moore, Camille D Brown, Carla J Lundi, Carol A Declouette Wilburn, Carol Mrivera Lopez, PhD, Charles B Steinmiller, Charles D Brown, Christopher D Rush, Christopher J Hurst, Claire M Minden, Constance M Dobbins, Cynthia A Harris, MD, RN, Cynthia F Kleppinger, MD, Daniel J Lahar, Daniel S Fam, Daniell Gill, Jr, Danielle Lyke, Darla J Christopher, David M Beltran, Deniza Karacic, Diane Cvan Leeuwen, Dr. Jason R Caballero, Dr. Sriram Subramaniam, PhD, Ed Gonzalez Vazquez, Edward D Mcdonald, Elisa M Fleming, Elizabeth A Girard, Elizabeth D Connell, Elkins, Ellen J Tave, Elvia J Cervantes, Erin L Mcfiren, Ernest Serna, III, Francis A Guidry, Frans E Mercado, Gajendiran Mahadevan, PhD, George C Amedro, George J Flynn, Gerald N Mcgirl, DDS, Geraldine D Sanders, Grant, Grant L Davis, Habacuc V Barrera, Hugh M Mcclure, II, Hung V Le, Hurst, Iris C Macinnes, Jacqueline A O'shaughnessy, PhD, James H Robinson, James M Kewley, James P Stumpff, Jeffrey R Wooley, Jeffrey W Shrifter, DPM, Jennifer L Sheehan, Jennifer Owens Dowdy, Jocelyn C Turner, Jodi M Gatica, Joel D Martinez, Johann M Fitch, John A Kadavil, PhD, John Ahearn, Joseph B Carballa, Joy L Ramsey, Kamara Tx, Kara A Scheibner, PhD, Karen C Daugherty, Kari M Johansen, Karlton T Watson, Katherine Szestypalow, Kathleen B Swat, Kevin T Nguyen, Latorie S Jones, Lauren E Skokan, Leighton K Ngai, Lillie M Young, Lisa M Pence, Lisa M Puttonen, Lisa R Whitt, Lloyd D Payne, Lourdes R Genera, Lowell R Oates, Lucas B Leake, Luis E Gonzalez, Maira P Brading, Margaret M Annes, Mark A Guerra, Mark C Flotte, Martha S Baldwin, Martin K Yan, PhD, Martin K Yau, PhD, Martinez, Mary R Reed, Melkamu Getie Kebtie, PhD, Michael D Skelly, PhD, Michael F Skelly, PhD, Michael P Sheehan, Mildred H Glasgow, Monique Rac Lester, Nancy A Bellamy, Nilufer M Tampal, PhD, Patricia M Jacobs, Patrick J Mcneilly, Paul E Frazier, Paula J Perry, Paulene M Wohlgemuth, Pitman, Rebecca C O Bryan, Rebecca C O'bryan, Rene R Ramirez, Richard T Riggie, Robert Barron, Robert D Tollefsen, Robert L Lewis, Jr, Robert T Lorenz, Rodriguez, Ronda R Loyd Jones, Ronnie Garza, Rose M Ashley, Roy R Rinc, Sam H Haidar, PhD, Samantha J Pinizzotto, D V M, Sandra A Hughes, Scott T Ballard, Sha'tina R Alridge, Sharon K Thoma, PharmD, Shawn E Larson, Shelby N Marler, Sina Shojaee, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Staci G Mcallister, State Agency, Stephanie D Crockett, Stephen D Brown, Steven Eastham, Steven L Strom, Suzanne G Demko, Sylvia E Gaytan, Tara A Gray, Terrance L Thomas, Thomas J Arista, Toby Vern H Hill, Torrance J Slayton, Travis M Beard, Tricia S Martinez, Tricia Y Samaniego, Trina K Vick, Trinidad D Barreras, Unnee Ranjan, Verlinda A Narcisse, Vickie J Kanion, Xikui Chen (nmi), PhD, Yaw O Osei, Young M Yoon, Yvette Mlacour Davis, Zachary L Miller, Zerita White

Patrick D Stone, MS's Documents

Publish Date Document Type Title
June, 2000 EIR Charles T Van Buren, MD/Clin Inv - EIR, 2000-06-20
August, 2005 FDA 483 Christopher J. Logothetis, MD, PI - Form 483, 2005-08-05
January, 2000 EIR Michael D Lesem, MD/Clin Inv - EIR, 2000-01-20
June, 2000 EIR Aman Buzdar, Md/Clinv - EIR, 2000-06-07
April, 2007 EIR Altasciences Company Inc. - EIR, 2007-05-23
December, 2004 FDA 483 Farouk Systems, Inc. - Form 483, 2004-11-23
January, 2005 EIR Janet Lowther, BS, CI - EIR, 2005-01-14
February, 2002 EIR BRI Institutional Review Board, Inc. - EIR, 2002-02-15
November, 2004 FDA 483 MD Anderson Cancer Center - Form 483, 2004-11-02
August, 2001 FDA 483 Stanislaw R Burzynski, MD - Form 483, 2001-08-10
December, 2008 FDA 483 BRI Institutional Review Board, Inc. - Form 483, 2008-12-10
February, 2002 FDA 483 BRI Institutional Review Board, Inc. - Form 483, 2002-02-15
January, 2001 EIR Adaani E Frost, MD, PI - EIR, 2001-01-25
April, 2010 EIR Stillmeadow Incorporated - EIR, 2010-04-28
November, 2004 EIR Massimo Cristofanilli, MD - EIR, 2004-11-03
September, 2000 FDA 483 S.R. Burzynski Manufacturing Facility - Form 483, 2000-09-13
November, 2004 EIR MD Anderson Cancer Center - EIR, 2004-11-02
August, 2006 EIR Jerry Mitchell - EIR, 2006-08-17
August, 2006 EIR Oscar "Howard" Frazier - EIR, 2006-08-31
May, 2010 FDA 483 Cetero Research - Form 483, 2010-05-07
August, 2000 EIR Monica W Thint, MD/Clin Inv - EIR, 2000-08-10
April, 2007 EIR Altasciences Company Inc. - EIR, 2007-05-23
March, 2005 FDA 483 PharMedium Services, Llc - Form 483, 2005-03-31
January, 2005 FDA 483 Response Janet Lowther, BS, CI - Form 483R, 2005-01-28
February, 2000 EIR Jorg J Pahl, MD - EIR, 2000-02-25
January, 2003 EIR Matthew N. Brams, M.D., CI - EIR, 2003-01-22
January, 2004 EIR NUVISAN GmbH - EIR, 2004-06-02
January, 2005 FDA 483 Janet Lowther, BS, CI - Form 483, 2005-01-14
October, 2005 EIR Adaani E Frost, MD, PI - EIR, 2005-10-21
February, 2000 EIR William Insull, Jr, Md/Clin Inv - EIR, 2000-02-07
December, 2000 EIR Issam I Raad, MD/Clin Inv - EIR, 2000-12-13
October, 2004 FDA 483 UT MD Anderson Cancer Center RDRC - Form 483, 2004-10-22
February, 2002 EIR Michael D Lesem, MD/Clin Inv - EIR, 2002-02-28
February, 2001 EIR Jonathan R L Schwartz, Md/CIin Inv - EIR, 2001-02-15
December, 2002 EIR Adelaide A Hebert, MD Clin Inv - EIR, 2002-12-20
November, 2004 FDA 483 Massimo Cristofanilli, MD - Form 483, 2004-11-03
March, 2002 EIR Merrick I Ross, MD - EIR, 2002-03-28
November, 2008 FDA 483 Gonzalez, Anneliese, M.D. - Form 483, 2008-11-20

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more